Clinical Trials Browser

Carcinoma, Uterine Neoplasms, Endometrial Neoplasms

NCT05277051 2026-03-23

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Clinical Trials

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer

A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)

DOMENICA

RODEO

RUBY-J

A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

DOVE

LiDer

SATELLITE

Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer